Xiaoyan Lu

4PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedEarly English languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 22, 2023
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis.

Xiaoyan Lu, Zheng-Yi Zhou, Yiqiao Xin

|Mar 19, 2023
Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis.

Xiaoyan Lu, James Jarrett, Susannah Sadler

|Dec 09, 2022
Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis.

Xiaoyan Lu, James Jarrett, Susannah Sadler

|Aug 02, 2019
Determinants of shingles vaccine acceptance in the United Kingdom.

Hélène Bricout, Laurence Torcel-Pagnon, Coralie Lecomte

Pageof 1

Frequent Collaborators

3 joint publications

Vipul Jairath

1 joint publications

Ana Wheelock